Rob de Knegt

Rob de Knegt is a Researcher at Erasmus MC, affiliated with the Department of Gastroenterology & Hepatology at Erasmus University Rotterdam. His work focuses on liver diseases, particularly chronic hepatitis B, fatty liver, and metabolic dysfunction-associated steatotic liver disease (MASLD). He investigates the interplay between metabolic disorders and viral infections in liver pathology, with a strong emphasis on epidemiology, pathogenesis, and therapeutic strategies. His research has contributed to understanding the global burden of liver diseases and their comorbidities.

Key research interests include the prevalence of liver diseases, fibrosis progression mechanisms, and the impact of metabolic syndrome components on liver outcomes. He has published extensively on pharmacological interventions for MASLD in type 2 diabetes patients and biomarkers for disease monitoring. His studies often involve large-scale systematic reviews and meta-analyses, highlighting the global health implications of these conditions.

Dr. de Knegt collaborates internationally, focusing on viral hepatitis and metabolic liver diseases. Though no scientific awards are explicitly mentioned, his prolific publication record indicates significant contributions to hepatology. He has supervised 9 research works, though specific advisee names are not listed here. His research is conducted within the Erasmus MC framework, leveraging interdisciplinary approaches to address liver disease challenges.